Freenome, Inc. (FRNM) News
Track canonical SquawkNews coverage tagged to FRNM, Freenome, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
FRNM initiated with Outperform at Leerink; PT $18
FRNM is initiated with an Outperform rating at Leerink and assigned a $18 price target, according to TradeXchange Newsdesk.
EQUITY | Aug 14, 2026, 10:27 AM UTC
H
FRNM Gets FDA Breakthrough Device Designation
FRNM's blood-based lung cancer screening test gets FDA breakthrough designation
EQUITY | Aug 12, 2026, 01:00 PM UTC
L
Freenome, Abbott announce FDA approval of SimpleScreen CRC
Freenome (FRNM) and...
EQUITY | Jul 27, 2026, 12:12 PM UTC